Hajime Uno

Generating author description...

All published works

Action	Title	Year	Authors
+	Inferences for the distribution of the duration of response in a comparative clinical study	2024	Ying Cui Bo Huang Lu Mao Hajime Uno L. J. Wei Lü Tian
+	Biomarkers in Oncology: Complexities in Biomarker-Driven Studies and Statistical Analysis	2024	Hajime Uno Miki Horiguchi
+ PDF Chat	Comparative Effectiveness Research with Average Hazard for Censored Time-to-Event Outcomes: A Numerical Study	2024	Hong Xiong Jean M. Connors Deborah Schrag Hajime Uno
+ PDF Chat	A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time-to-Event Outcomes Using Average Hazard with Survival Weight	2024	Zihan Qian Lü Tian Miki Horiguchi Hajime Uno
+	Regression models for average hazard	2024	Hajime Uno Lü Tian Miki Horiguchi Satoshi Hattori Kenneth L. Kehl
+ PDF Chat	Assessing Delayed Treatment Benefits of Immunotherapy Using Long-Term Average Hazard: A Novel Test/Estimation Approach	2024	Miki Horiguchi Lü Tian Kenneth L. Kehl Hajime Uno
+ PDF Chat	Multiply robust causal inference of the restricted mean survival time difference	2023	Di Shu Sagori Mukhopadhyay Hajime Uno Jeffrey S. Gerber Douglas E. Schaubel
+ PDF Chat	Combining Breast Cancer Risk Prediction Models	2023	Zoe Guan Theodore Huang Anne Marie McCarthy Kevin S. Hughes Alan Semine Hajime Uno Lorenzo Trippa Giovanni Parmigiani Danielle Braun
+ PDF Chat	On assessing survival benefit of immunotherapy using long‐term restricted mean survival time	2023	Miki Horiguchi Lü Tian Hajime Uno
+ PDF Chat	Quantifying Treatment Effects in Trials with Multiple Event-Time Outcomes	2022	Brian Claggett Zachary R. McCaw Lü Tian John J.V. McMurray Pardeep S. Jhund Hajime Uno Marc A. Pfeffer Scott D. Solomon L. J. Wei
+	Semi-supervised approach to event time annotation using longitudinal electronic health records	2022	Liang Liang Jue Hou Hajime Uno Kelly Cho Yanyuan Ma Tianxi Cai
+	On sample size determination for restricted mean survival time-based tests in randomized clinical trials	2022	Satoshi Hattori Hajime Uno
+ PDF Chat	OptBand: optimization-based confidence bands for functions to characterize time-to-event distributions	2021	T. Chen Samuel Tracy Hajime Uno
+	Semi-supervised Approach to Event Time Annotation Using Longitudinal Electronic Health Records	2021	Liang Liang Jue Hou Hajime Uno Kelly Cho Yanyuan Ma Tianxi Cai
+	Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology	2020	Miki Horiguchi Michael J. Hassett Hajime Uno
+	On permutation tests for comparing restricted mean survival time with small sample from randomized trials	2020	Miki Horiguchi Hajime Uno
+	On the empirical choice of the time window for restricted mean survival time	2020	Lü Tian Hua Jin Hajime Uno Ying Lü Bo Huang Keaven M. Anderson L. J. Wei
+	Combining Breast Cancer Risk Prediction Models	2020	Zoe Guan Theodore Huang Anne Marie McCarthy Kevin S. Hughes Alan Semine Hajime Uno Lorenzo Trippa Giovanni Parmigiani Danielle Braun
+ PDF Chat	Statistical Test/Estimation Methods Used in Contemporary Phase III Cancer Randomized Controlled Trials with Time-to-Event Outcomes	2019	Hajime Uno Miki Horiguchi Michael J. Hassett
+	Assessing Clinical Equivalence in Oncology Biosimilar Trials With Time-to-Event Outcomes	2019	Hajime Uno Deborah Schrag Dae Hyun Kim Dejun Tang Lü Tian Hope S. Rugo L. J. Wei
+	Unifying Design and Analysis for Superiority and Noninferiority Trials With Appropriate End Point	2019	Brian Claggett Hajime Uno L. J. Wei
+	Moving beyond the conventional stratified analysis to estimate an overall treatment efficacy with the data from a comparative randomized clinical study	2018	Lü Tian Feng Jiang Tomoko Hasegawa Hajime Uno Michael Pfeffer LJ. Wei
+	A flexible and coherent test/estimation procedure based on restricted mean survival times for censored time‐to‐event data in randomized clinical trials	2018	Miki Horiguchi Angel M. Cronin Masahiro Takeuchi Hajime Uno
+	Evaluating Noninferiority With Clinically Interpretable Statistics for the PROSELICA Study to Assess Treatment Efficacy of a Reduced Dose of Cabazitaxel for Treating Metastatic Prostate Cancer	2018	Miki Horiguchi Hajime Uno L. J. Wei
+ PDF Chat	Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio	2017	Kyongsun Pak Hajime Uno Dae Hyun Kim Lü Tian Robert C. Kane Masahiro Takeuchi Haoda Fu Brian Claggett L. J. Wei
+	Efficiency of Two Sample Tests via the Restricted Mean Survival Time for Analyzing Event Time Observations	2017	Lü Tian Haoda Fu Stephen J. Ruberg Hajime Uno L. J. Wei
+	Decision on performing interim analysis for comparative clinical trials	2017	Kyongsun Pak Susanna Jacobus Hajime Uno
+ PDF Chat	Strmst2 and Strmst2pw: New Commands to Compare Survival Curves Using the Restricted Mean Survival time	2016	Angel M. Cronin Lü Tian Hajime Uno
+ PDF Chat	On the Restricted Mean Survival Time Curve in Survival Analysis	2015	Lihui Zhao Brian Claggett Lü Tian Hajime Uno Marc A. Pfeffer Scott D. Solomon Lorenzo Trippa L. J. Wei
+ PDF Chat	A versatile test for equality of two survival functions based on weighted differences of Kaplan–Meier curves	2015	Hajime Uno Lü Tian Brian Claggett L. J. Wei
+ PDF Chat	Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies	2015	Hajime Uno Janet Wittes Haoda Fu Scott D. Solomon Brian Claggett Lü Tian Tianxi Cai Marc A. Pfeffer Scott Evans L. J. Wei
+ PDF Chat	Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis	2014	Hajime Uno Brian Claggett Lü Tian Eisuke Inoue Paul Gallo Toshio Miyata Deborah Schrag Masahiro Takeuchi Yoshiaki Uyama Lihui Zhao
+ PDF Chat	A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data	2012	Hajime Uno Lü Tian Tianxi Cai Isaac S. Kohane L. J. Wei
+ PDF Chat	Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study	2012	Lihui Zhao Lü Tian Hajime Uno Scott D. Solomon Marc A. Pfeffer Jerald Schindler Lee Jen Wei
+	Predicting Binary Outcomes Using Trajectory Classes	2012	Nami Maruyama Fumiaki Takahashi Hajime Uno Masahiro Takeuchi
+ PDF Chat	On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data	2011	Hajime Uno Tianxi Cai Michael Pencina Ralph B. D’Agostino L. J. Wei
+ PDF Chat	Calibrating parametric subject-specific risk estimation	2010	Tianxi Cai Lü Tian Hajime Uno Scott D. Solomon L. J. Wei
+	Stratifying Subjects for Treatment Selection with Censored Event Time Data from a Comparative Study	2010	Lihui Zhao Tianxi Cai Lü Tian Hajime Uno Scott D. Solomon L. J. Wei
+	Comparing Risk Scoring Systems Beyond the ROC Paradigm in Survival Analysis	2009	Hajime Uno Lü Tian Tianxi Cai Isaac S. Kohane L. J. Wei
+ PDF Chat	Predicted Interval Plots (PIPS): A Graphical Tool for Data Monitoring of Clinical Trials	2009	Lingling Li Scott Evans Hajime Uno L. J. Wei
+	Evaluating Prediction Rules for<i>t</i>-Year Survivors With Censored Regression Models	2007	Hajime Uno Tianxi Cai Lü Tian L. J. Wei
+ PDF Chat	The optimal confidence region for a random parameter	2005	Hajime Uno Lü Tian L. J. Wei
+	The Optimal Confidence Region for a Random Parameter	2004	Hajime Uno Lü Tian Laifu Wei
+ PDF Chat	Bayesian Approaches to Interim Monitoring of Clinical Trials: A Review of Recent Theoretical Developments	2000	Hajime Uno Shigeyuki Matsui Nobuyuki Koyama
+ PDF Chat	Frequentist Approaches to Interim Monitoring of Clinical Trials: A Review of Recent Theoretical Developments	2000	Shigeyuki Matsui Hajime Uno Nobuyuki Koyama

Common Coauthors

Coauthor	Papers Together
Lü Tian	24
L. J. Wei	10
Miki Horiguchi	10
L. J. Wei	10
Tianxi Cai	9
Brian Claggett	7
Scott D. Solomon	7
Masahiro Takeuchi	4
Marc A. Pfeffer	4
Lihui Zhao	4
Lorenzo Trippa	3
Haoda Fu	3
Deborah Schrag	3
Giovanni Parmigiani	2
Shigeyuki Matsui	2
Michael J. Hassett	2
Alan Semine	2
Zoe Guan	2
Angel M. Cronin	2
Dae Hyun Kim	2
Theodore Huang	2
Kenneth L. Kehl	2
Susanna Jacobus	2
Yanyuan Ma	2
Bo Huang	2
Danielle Braun	2
Isaac S. Kohane	2
Scott Evans	2
Kelly Cho	2
Anne Marie McCarthy	2
Liang Liang	2
Kyongsun Pak	2
Kevin S. Hughes	2
Stephen J. Ruberg	1
Jerald Schindler	1
Hope S. Rugo	1
Lingling Li	1
Ying Cui	1
Jue Hou	1
Satoshi Hattori	1
Laifu Wei	1
Hua Jin	1
LJ. Wei	1
Zihan Qian	1
Paul Gallo	1
Robert C. Kane	1
Di Shu	1
Lee Jen Wei	1
Jue Hou	1
Milton Packer	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+ PDF Chat	Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis	2014	Hajime Uno Brian Claggett Lü Tian Eisuke Inoue Paul Gallo Toshio Miyata Deborah Schrag Masahiro Takeuchi Yoshiaki Uyama Lihui Zhao	17
+	The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt	2011	Patrick Royston Mahesh Parmar	17
+ PDF Chat	Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies	2015	Hajime Uno Janet Wittes Haoda Fu Scott D. Solomon Brian Claggett Lü Tian Tianxi Cai Marc A. Pfeffer Scott Evans L. J. Wei	13
+ PDF Chat	Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome	2013	Patrick Royston Mahesh Parmar	12
+ PDF Chat	Counting Processes and Survival Analysis.	1992	Dorota M. Dabrowska Thomas R. Fleming David P. Harrington	11
+ PDF Chat	Predicting the restricted mean event time with the subject's baseline covariates in survival analysis	2013	Lü Tian Lihui Zhao L. J. Wei	9
+ PDF Chat	Checking the Cox model with cumulative sums of martingale-based residuals	1993	D. Y. Lin L. J. Wei Z. Ying	9
+ PDF Chat	Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves	2012	Patricia Guyot A. E. Ades Mario JNM Ouwens Nicky J. Welton	9
+ PDF Chat	Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study	2012	Lihui Zhao Lü Tian Hajime Uno Scott D. Solomon Marc A. Pfeffer Jerald Schindler Lee Jen Wei	8
+	Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials	2016	Ludovic Trinquart Justine Jacot Sarah C. Conner Raphaël Porcher	8
+	Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials?	2016	Roger A’Hern	7
+ PDF Chat	On the Restricted Mean Survival Time Curve in Survival Analysis	2015	Lihui Zhao Brian Claggett Lü Tian Hajime Uno Marc A. Pfeffer Scott D. Solomon Lorenzo Trippa L. J. Wei	6
+	Restricted Mean Life with Covariates: Modification and Extension of a Useful Survival Analysis Method	1998	David M. Zucker	6
+ PDF Chat	The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials	2016	Julien Péron Pascal Roy Brice Ozenne Laurent Roche Marc Buyse	6
+ PDF Chat	On Inference in Parametric Survival Data Models	1992	Nils Lid Hjort	6
+	Estimation of the average hazard ratio	1981	John D. Kalbfleisch Ross L. Prentice	6
+ PDF Chat	Large Sample Behaviour of the Product-Limit Estimator on the Whole Line	1983	Richard D. Gill	5
+	The Robust Inference for the Cox Proportional Hazards Model	1989	D. Y. Lin L. J. Wei	5
+ PDF Chat	On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data	2011	Hajime Uno Tianxi Cai Michael Pencina Ralph B. D’Agostino L. J. Wei	5
+	Simultaneous Confidence Intervals for the Difference of Two Survival Functions	1997	Michael Parzen L. J. Wei Z. Ying	5
+ PDF Chat	Sequential Methods for Comparing Years of Life Saved in the Two‐Sample Censored Data Problem	1999	Susan Murray Anastasios A. Tsiatis	5
+	Efficiency of Two Sample Tests via the Restricted Mean Survival Time for Analyzing Event Time Observations	2017	Lü Tian Haoda Fu Stephen J. Ruberg Hajime Uno L. J. Wei	5
+ PDF Chat	Statistical Test/Estimation Methods Used in Contemporary Phase III Cancer Randomized Controlled Trials with Time-to-Event Outcomes	2019	Hajime Uno Miki Horiguchi Michael J. Hassett	5
+	Analysis of transformation models with censored data	1995	Sen Cheng L. J. Wei Z. Ying	5
+ PDF Chat	Weighted Kaplan-Meier Statistics: A Class of Distance Tests for Censored Survival Data	1989	Margaret S. Pepe Thomas R. Fleming	5
+	Restricted Mean Life with Adjustment for Covariates	1987	Theodore Karrison	5
+	Weighted Kaplan-Meier Statistics: Large Sample and Optimality Considerations	1991	Margaret S. Pepe Thomas R. Fleming	5
+	The Hazards of Hazard Ratios	2009	Miguel A. Hernán	5
+ PDF Chat	Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening Marker	2004	M. S. Pepe	4
+	Jackknife, Bootstrap and Other Resampling Methods in Regression Analysis	1986	C. F. Jeff Wu	4
+	The accelerated failure time model: A useful alternative to the cox regression model in survival analysis	1992	L. J. Wei	4
+ PDF Chat	Survival Model Predictive Accuracy and ROC Curves	2005	Patrick J. Heagerty Yingye Zheng	4
+	On the empirical choice of the time window for restricted mean survival time	2020	Lü Tian Hua Jin Hajime Uno Ying Lü Bo Huang Keaven M. Anderson L. J. Wei	4
+	Misspecified proportional hazard models	1986	C. A. Struthers John D. Kalbfleisch	4
+	Linear rank tests with right censored data	1978	Ross L. Prentice	4
+	Regression Analysis of Restricted Mean Survival Time Based on Pseudo-Observations	2004	Per Kragh Andersen Mette Gerster Hansen John P. Klein	4
+ PDF Chat	Estimating average regression effect under non-proportional hazards	2000	Ronghui Xu	4
+ PDF Chat	The standard error of an estimate of expectation of life, with special reference to expectation of tumourless life in experiments with mice	1949	J. O. Irwin	4
+	Regression Analysis of Censored Data Using Pseudo-observations	2010	Erik Thorlund Parner Per Kragh Andersen	3
+	The Statistical Evaluation of Medical Tests for Classification and Prediction	2005	Margaret S. Pepe	3
+	Group sequential methods in the design and analysis of clinical trials	1977	Stuart J. Pocock	3
+	Empirical Processes: Theory and Applications	1990	David Pollard	3
+	Consistent Estimation of the Expected Brier Score in General Survival Models with Right‐Censored Event Times	2006	Thomas A. Gerds Martin Schumacher	3
+	Approximately Optimal One-Parameter Boundaries for Group Sequential Trials	1987	Samuel K. Wang Anastasios A. Tsiatis	3
+	On distribution-free tests for equality of survival distributions	1977	Robert E. Tarone James S. Ware	3
+	The Versatility of Function-Indexed Weighted Log-Rank Statistics	1999	Michael R. Kosorok Chin-Yu Lin	3
+	The area above the ordinal dominance graph and the area below the receiver operating characteristic graph	1975	Donald Bamber	3
+	The asymptotic properties of nonparametric tests for comparing survival distributions	1981	David Schoenfeld	3
+	Discrete sequential boundaries for clinical trials	1983	K. K. Gordon Lan David L. DeMets	3
+	Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis	1994	S. Pampallona Anastasios A. Tsiatis	3